Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
May 12 ADMA Giving ADMA Biologics A Well-Deserved 'Booyah'
May 11 ADMA ADMA Biologics First Quarter 2024 Earnings: Beats Expectations
May 10 THRD Insider Sale: CEO Natalie Holles Sells Shares of Third Harmonic Bio Inc (THRD)
May 10 MACK Merrimack Pharmaceuticals stockholders approve plan of dissolution
May 10 MACK Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval of Plan of Dissolution And Cash Liquidating Dividend Amount of $15.10 Per Share of Common Stock
May 10 ADMA ADMA Biologics hits 52-week high on Q1 beat, guidance raise
May 10 ADMA ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Call Transcript
May 10 EWTX Edgewise: Intriguing Drug Candidate, But Consider Selling After Recent Run
May 10 EWTX Edgewise Therapeutics Inc (EWTX) Reports First Quarter 2024 Financial Results
May 10 ADMA ADMA Biologics Inc (ADMA) Surpasses Analyst Revenue and Earnings Forecasts in Q1 2024
May 10 DCPH Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings
May 10 EWTX Edgewise Therapeutics files mixed securities shelf
May 10 DCPH Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates
May 10 EWTX Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024
May 10 ADMA ADMA Biologics, Inc. (ADMA) Q1 2024 Earnings Call Transcript
May 9 ADMA Adma Biologics (ADMA) Surpasses Q1 Earnings and Revenue Estimates
May 9 RNA Avidity Biosciences GAAP EPS of -$0.79 beats by $0.07, revenue of $3.54M beats by $0.97M
May 9 RNA Avidity Biosciences files automatic mixed shelf
May 9 ADMA ADMA Biologics GAAP EPS of $0.08 beats by $0.02, revenue of $81.9M beats by $4.62M
May 9 ADMA ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags